Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.690
+0.270 (11.16%)
At close: Jan 16, 2026, 4:00 PM EST
2.680
-0.010 (-0.37%)
After-hours: Jan 16, 2026, 7:49 PM EST
Veru Inc. Market Cap
Veru Inc. has a market cap or net worth of $43.18 million as of January 16, 2026. Its market cap has decreased by -54.65% in one year.
Market Cap
43.18M
Enterprise Value
43.77M
1-Year Change
-54.65%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since December 1, 1998, Veru Inc.'s market cap has increased from $15.60M to $43.18M, an increase of 176.77%. That is a compound annual growth rate of 3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 43.20M | 25.95% |
| Dec 31, 2025 | 34.30M | -63.97% |
| Dec 31, 2024 | 95.20M | 41.25% |
| Dec 29, 2023 | 67.40M | -84.17% |
| Dec 30, 2022 | 425.70M | -9.69% |
| Dec 31, 2021 | 471.40M | -22.24% |
| Dec 31, 2020 | 606.20M | 178.20% |
| Dec 31, 2019 | 217.90M | 148.46% |
| Dec 31, 2018 | 87.70M | 44.48% |
| Dec 29, 2017 | 60.70M | 112.98% |
| Dec 30, 2016 | 28.50M | -32.30% |
| Dec 31, 2015 | 42.10M | -62.74% |
| Dec 31, 2014 | 113.00M | -53.73% |
| Dec 31, 2013 | 244.20M | 18.60% |
| Dec 31, 2012 | 205.90M | 63.80% |
| Dec 30, 2011 | 125.70M | -19.63% |
| Dec 31, 2010 | 156.40M | 24.42% |
| Dec 31, 2009 | 125.70M | 30.39% |
| Dec 31, 2008 | 96.40M | 38.31% |
| Dec 31, 2007 | 69.70M | 85.87% |
| Dec 29, 2006 | 37.50M | -7.64% |
| Dec 30, 2005 | 40.60M | -11.74% |
| Dec 31, 2004 | 46.00M | -14.34% |
| Dec 31, 2003 | 53.70M | 88.42% |
| Dec 31, 2002 | 28.50M | 139.50% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |